Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
North America (Primary) | PRIMARYNOAM | Univ | 8,153 | 59,660,184 | 0.15% | 1.60% | 6.01% | 6.51% | 16.95% | 26.43% |
Healthcare | HEALTHCARE | Sector | 1,332 | 6,612,521 | 0.02% | 1.84% | 6.01% | 1.11% | 14.01% | 14.79% |
Biopharmaceuticals | BIOPHARMA | SubSec | 675 | 3,052,063 | -0.07% | 1.91% | 4.34% | -1.11% | 23.67% | 30.73% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 309 | 1,574,627 | 0.13% | 2.15% | 4.25% | 0.24% | 22.96% | 18.88% |
Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 30 | 27,690 | -1.64% | 0.60% | 4.46% | -0.31% | 31.01% | -0.05% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals, Inc. | IRWD:USAIRWD:USA | Stock | 1 | 1,030 | -2.41% | -7.43% | -14.74% | -56.30% | -31.36% | -36.59% |
Verve Therapeutics, Inc. | VERV:USAVERV:USA | Stock | 1 | 501 | -6.27% | -0.50% | -10.21% | -54.21% | -45.54% | -63.40% |
Akero Therapeutics, Inc. | AKRO:USAAKRO:USA | Stock | 1 | 1,377 | -3.91% | 1.37% | -2.88% | -7.86% | 37.95% | -56.32% |
Madrigal Pharmaceuticals, Inc. | MDGL:USAMDGL:USA | Stock | 1 | 4,374 | 1.33% | 7.22% | -0.99% | -4.20% | 30.45% | -20.41% |
Mirum Pharmaceuticals, Inc. | MIRM:USAMIRM:USA | Stock | 1 | 1,133 | -2.75% | -2.79% | 2.12% | -17.26% | -20.59% | -7.60% |
Viking Therapeutics, Inc. | VKTX:USAVKTX:USA | Stock | 1 | 7,385 | -2.98% | -9.02% | 3.60% | 87.47% | 536.28% | 189.04% |
Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 30 | 27,690 | -1.64% | 0.60% | 4.46% | -0.31% | 31.01% | -0.05% |
S&P 500 | SPY:USASPY:USA | Benchmark | 14,717 | 77,876,547 | 0.14% | 1.65% | 5.99% | 6.91% | 18.44% | 28.12% |
Spyre Therapeutics, Inc. | SYRE:USASYRE:USA | Stock | 1 | 1,385 | 0.00% | 2.36% | 6.24% | 72.21% | 278.38% | 929.27% |
Morphic Holding, Inc. | MORF:USAMORF:USA | Stock | 1 | 1,464 | -9.92% | 2.13% | 6.25% | -18.62% | 26.48% | -48.37% |
Arbutus Biopharma Corp. | ABUS:USAABUS:USA | Stock | 1 | 537 | 3.11% | 3.47% | 9.16% | 3.47% | 61.08% | 19.20% |
Arrowhead Pharmaceuticals, Inc. | ARWR:USAARWR:USA | Stock | 1 | 3,075 | -0.92% | 12.18% | 9.55% | -15.23% | -4.95% | -31.73% |
Phathom Pharmaceuticals, Inc. | PHAT:USAPHAT:USA | Stock | 1 | 617 | -1.40% | 10.66% | 11.18% | 3.64% | 43.79% | -18.55% |
Ardelyx, Inc. | ARDX:USAARDX:USA | Stock | 1 | 1,827 | 0.26% | 0.51% | 21.27% | -8.65% | 93.80% | 114.56% |
Wave Life Sciences Ltd. | WVE:USAWVE:USA | Stock | 1 | 766 | 6.10% | 11.39% | 30.42% | 52.31% | 14.03% | 75.84% |
* Colors indicate performance relative to the benchmark.